一个闭环胆固醇分流控制实验性失脂症.
Gokberk Unal1, Yu-Qing Xie1, Martin Fussenegger2
1Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Schanzenstrasse 48, 4056 Basel, Switzerland.
Cell metabolism
|September 19, 2025
概括
一个新的遗传电路,CHARM,有效地感知并实时调节高胆固醇水平. 这种工程系统恢复了高胆固醇贫血小鼠的胆固醇稳态,为治疗失脂症提供了新的治疗策略.
科学领域:
- 生物技术和基因工程 生物技术和基因工程
- 代谢障碍和心血管健康
- 合成生物学应用 合成生物学应用
背景情况:
- 超高胆固醇血症的特征是脂质代谢失调,是动脉样硬化和心血管疾病的主要危险因素.
- 目前治疗失脂症的治疗策略在实时监测和持续调节方面面临挑战.
- 需要创新的方法来恢复和维持胆固醇平衡至关重要.
研究的目的:
- 开发一个设计基因电路,即胆固醇恒常和调节模块 (CHARM),用于实时感知和调节胆固醇水平.
- 设计一个闭环系统,加强身体的先天胆固醇恒常机制.
- 在临床前模型中评估CHARM在恢复胆固醇平衡方面的有效性.
主要方法:
- 设计了一种合成遗传电路 (CHARM),使用融合蛋白 (KRAB-SREBP1a) 作为胆固醇传感器.
- 集成了一个合成表达模块与SRE操作员站点,以控制治疗性蛋白质的生产.
- 植入微封装的CHARM转基因人体细胞进入高胆固醇贫血小鼠.
主要成果:
- 魅力成功地在实时感知高胆固醇水平.
- 植入CHARM转基因细胞在高胆固醇贫血小鼠中迅速恢复胆固醇平衡.
- 通过遗传电路的闭环调节,可以稳定地维持胆固醇平衡.
结论:
- CHARM遗传电路代表了一种有前途的合成生物学方法,用于管理高胆固醇血症.
- 这种工程系统证明了对代谢障碍的闭环,实时调节的潜力.
- 魅力为恢复和维持胆固醇平衡提供了一种新的策略,可能降低心血管疾病风险.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Lipid Absorption
2.5K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.5K


